piperaquine has been researched along with Malaria, Vivax in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (18.00) | 29.6817 |
| 2010's | 30 (60.00) | 24.3611 |
| 2020's | 11 (22.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batty, KT; Davis, TM; Ilett, KF; Karunajeewa, HA; Lammey, J; Law, I; Lin, E; Mueller, I; Page-Sharp, M; Siba, P | 1 |
| Anggraeni, ND; Asih, PBS; Basri, HH; Bustos, MDG; Dewayanti, FK; Hutahaean, J; Kusumaningsih, M; Mulyani, PS; Robaha, M; Rozi, IE; Sariwati, E; Syafruddin, D; Wangsamuda, S; Zulfah, S | 1 |
| Siahaan, L | 1 |
| Assefa, A; Bekele, W; Chernet, M; Commons, RJ; Etana, K; Gidey, B; Girma, S; Gubae, K; Haile, M; Hailgiorgis, H; Mohammed, H; Sime, H; Solomon, H; Tasew, G; Tollera, G | 1 |
| Abera, A; Alemayehu, BH; Anand, A; Assefa, A; Bekele, W; Dilu, D; Etana, K; Ezema, B; Girma, S; Haile, M; Hwang, J; Minta, AA; Mohammed, H; Moriarty, LF; Murphy, M; Sime, H; Solomon, H; Svigel, SS; Tadesse, M; Tadesse, Y; Tasew, G; Teka, H; Woyessa, A; Zhou, Z | 1 |
| Baird, JK; Berni, A; Budiman, W; Cedar, E; Chand, K; Crenna-Darusallam, C; Duparc, S; Ekawati, LL; Elyazar, I; Fernando, D; Fletcher, K; Goyal, N; Green, JA; Instiaty, I; Jones, S; Kleim, JP; Lardo, S; Martin, A; Noviyanti, R; Prasetya, CB; Rolfe, K; Santy, YW; Satyagraha, AW; Sharma, H; Soebandrio, A; Subekti, D; Sutanto, I; Tan, LK; Taylor, M | 1 |
| Arcelia, F; Pasaribu, AP; Yanni, GN | 1 |
| Kuesap, J; Rungsihirunrat, K; Suphakhonchuwong, N | 1 |
| Benjamin, JM; Davis, TME; Kasian, B; Kong, C; Laman, M; Moore, BR; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, S; Tobe, R; Yadi, G | 1 |
| Abreha, T; Adam, I; Anstey, NM; Assefa, A; Awab, GR; Baird, JK; Barber, BE; Chu, CS; Commons, RJ; Dahal, P; Daher, A; Davis, TME; Dondorp, AM; Grigg, MJ; Guerin, PJ; Hien, TT; Humphreys, GS; Hwang, J; Karunajeewa, H; Laman, M; Lidia, K; Moore, BR; Mueller, I; Nosten, F; Pasaribu, AP; Pereira, DB; Phyo, AP; Poespoprodjo, JR; Price, RN; Sibley, CH; Simpson, JA; Stepniewska, K; Sutanto, I; Thriemer, K; Thwaites, G; White, NJ; William, T; Woodrow, CJ | 1 |
| Adhikari, B; Cobelens, F; Day, NPJ; Dhorda, M; Dondorp, AM; Henriques, G; Imwong, M; Mayxay, M; Mukaka, M; Newton, PN; Peerawaranun, P; Peto, TJ; Phommasone, K; Pongvongsa, T; Promnarate, C; Sirithiranont, P; van Leth, F; von Seidlein, L; White, NJ | 1 |
| Adhikari, B; Cheah, PY; Chotivanich, K; Cobelens, F; Davoeung, C; Day, NPJ; Dhorda, M; Dondorp, AM; Hanboonkunupakarn, B; Hien, TT; Imwong, M; Jittmala, P; Kajeechiwa, L; Landier, J; Lwin, KM; Mayxay, M; Mukaka, M; Newton, PN; Nguon, C; Nguyen, TN; Nosten, FH; Nosten, S; Parker, DM; Peerawaranun, P; Peto, TJ; Phommasone, K; Pongvongsa, T; Promnarate, C; Proux, S; Pukrittayakamee, S; Rekol, H; Thwaites, GE; Thwin, MM; Tripura, R; van Leth, F; von Seidlein, L; White, NJ; Wiladphaingern, J | 1 |
| Kim, S; Lek, D; Mairet-Khedim, M; Popovici, J; Roesch, C; Witkowski, B | 1 |
| Arsanok, M; Chann, S; Dysoley, L; Jongsakul, K; Kheang Heng, T; Kuntawunginn, W; Lin, JT; Lon, C; Manning, JE; Nou, S; Pichyangkul, S; Satharath, P; Saunders, DL; Sea, D; Smith, PL; Sok, S; Spring, MD; Sriwichai, S; Vanachayangkul, P; Waters, NC; Wojnarski, M | 1 |
| Anstey, NM; Douglas, NM; Kenangalem, E; Malloy, MJ; Patriani, D; Poespoprodjo, JR; Price, RN; Simpson, JA; Soenarto, Y; Sugiarto, P | 1 |
| Bin, S; Kim, S; Lek, D; Menard, D; Piv, EP; Popovici, J; Primault, L; Samreth, R; Serre, D; Vantaux, A | 1 |
| Blessborn, D; Chairat, K; Day, NPJ; Hanboonkunupakarn, B; Hanpithakpong, W; Jittamala, P; Pukrittayakamee, S; Tarning, J; White, NJ | 1 |
| Abel, H; Bassat, Q; Ila, R; Karunajeewa, H; Laman, M; Manning, L; Millat-Martínez, P; Mitjà, O; Moore, B; Pulai, K; Robinson, L; Sanz, S | 1 |
| Hetzel, MW; Karl, S; Kattenberg, JH; Kiniboro, B; Laman, M; Makita, L; Mueller, I; Oswyn, G; Pulford, J; Rare, L; Robinson, L; Siba, PM; Tavul, L; Teliki, A; Walsh, D | 1 |
| Birrell, GW; Chavchich, M; Chuang, I; Edstein, MD; Manh, ND; Martin, NJ; Phong, NC; Quang, HH; San, NN | 1 |
| Day, NPJ; Dhorda, M; Dondorp, AM; Duanguppama, J; Imwong, M; Mathema, VB; Maxay, M; Nguon, C; Nosten, F; Peto, TJ; Tripura, R; von Seidlein, L; White, NJ | 1 |
| Bancone, G; Carrara, VI; Chu, CS; Imwong, M; Jeeyapant, A; Lee, SJ; Nosten, F; Paw, MK; Phyo, AP; Poe, NP; Proux, S; Raksapraidee, R; Sriprawat, K; Tarning, J; Thinraow, S; Turner, C; Watson, J; White, NJ; Wiladphaingern, J; Wilairisak, P; Win, HH; Yotyingaphiram, W | 1 |
| Adams, ER; Ahmed, R; Asih, PBS; Chen, T; Faragher, B; Khairallah, C; Lukito, T; Maratina, SS; Pace, C; Poespoprodjo, JR; Price, RN; Santana-Morales, MA; Smedley, J; Syafruddin, D; Ter Kuile, FO; Unwin, VT; Wang, D; Williams, CT | 1 |
| Chavez, I; Chokejindachai, W; Dondorp, AM; Imwong, M; Pasaribu, AP; Pasaribu, S; Sirivichayakul, C; Tanomsing, N; Tjitra, E; White, NJ | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Gogtay, N; Kannan, S; Olliaro, PL; Sinclair, D; Thatte, UM | 1 |
| Aung, K; Mak, JW; Naing, C; Racloz, V; Reid, SA; Tanner, M; Whittaker, MA | 1 |
| Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Bethell, D; Buathong, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Juliano, JJ; Kaewkungwal, J; Kuntawunginn, W; Lanteri, C; Lin, J; Lon, C; Manning, JE; Nou, S; Satharath, P; Saunders, D; Se, Y; Sea, D; So, M; Spring, M; Sriwichai, S; Tang, D; Tyner, SD; Vanachayangkul, P; Walsh, DS | 1 |
| Auburn, S; Handayuni, I; Marfurt, J; Noviyanti, R; Pava, Z; Poespoprodjo, JR; Price, RN; To, S; Trianty, L; Wirjanata, G | 1 |
| Anvikar, AR; Arora, S; Gogtay, N; Iyer, SS; Jalali, RK; Kochar, SK; Kumar, NB; Lakhani, JD; Rajadhyaksha, GC; Rao, BH; Roy, A; Saha, N; Savargaonkar, D; Sharma, P; Solanki, BB; Srivastava, B; Tripathi, SK; Valecha, N | 1 |
| Anh, ND; Ca, NTN; Dolecek, C; Dong, LT; Farrar, J; Hien, TT; Hoa, NT; Khanh, TTN; Loi, MA; Nhan, HT; Nhien, NTT; Phu, NH; Son, DH; Thai, CQ; Thai, LH; Thanh, NV; Thuan, PD; Thwaites, G; Van Toi, P; White, NJ; Wolbers, M | 1 |
| Bouhired, S; Duparc, S; Goyal, N; Green, JA; Hussaini, A; Jones, SW; Koh, GC; Kostov, I; Mohamed, K; Taylor, M; Wolstenholm, A | 1 |
| Anstey, NM; Burdarm, L; Devine, A; Karyana, M; Kenangalem, E; Poespoprodjo, JR; Price, RN; Tjitra, E; Vemuri, R; Yeung, S | 1 |
| Rogerson, SJ; Unger, HW | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Awab, GR; Day, NP; Dondorp, AM; Imwong, M; Kaker, F; Lee, SJ; Pukrittayakamee, S; Singhasivanon, P; White, NJ; Woodrow, CJ | 1 |
| Anstey, NM; Fobia, W; Hasanuddin, A; Kenangalem, E; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Bassat, Q; Cenci, F; Gargano, N | 1 |
| Ashley, EA; Lindegardh, N; Lwin, KM; Nosten, F; Phyo, AP; Price, RN; Russell, B; Singhasivanon, P; Sriprawat, K; White, NJ | 1 |
| Ashley, EA; Cheah, P; Hanpithakpong, W; Lee, SJ; Lindegårdh, N; Lwin, KM; Nosten, F; Phyo, AP; Singhasivanon, P; Tarning, J; White, NJ | 1 |
| Abdur, R; Barrette, A; Bouth, DM; Duong, S; Leang, R; Menard, D; Ringwald, P | 1 |
| Baird, JK; Basri, H; Ekawati, LL; Elyazar, I; Farrar, J; Meilia, RA; Nurleila, S; Putri, FA; Setiabudy, R; Sudoyo, H; Sutanto, I; Taylor, WR; Tjahjono, B | 1 |
| Davis, TM; Denis, MB; Hung, TY; Ilett, KF; Karunajeewa, H; Lim, C; Socheat, D | 1 |
| Davis, TM; Denis, MB; Hewitt, S; Hung, TY; Ilett, KF; Karunajeewa, H; Lim, C; Socheat, D | 1 |
| Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
| Anstey, NM; Ebsworth, EP; Kenangalem, E; Laihad, F; Maristela, R; Price, RN; Ratcliff, A; Siswantoro, H; Tjitra, E; Wuwung, RM | 1 |
| Anstey, NM; Ebsworth, EP; Hasugian, AR; Kenangalem, E; Laihad, F; Maristela, R; Penttinen, PM; Price, RN; Purba, HL; Tjitra, E; Wuwung, RM | 1 |
| Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; McGready, R; Poespoprodjo, JR; Price, RN; Seal, A; Sugiarto, P; Tjitra, E; Warikar, N | 1 |
7 review(s) available for piperaquine and Malaria, Vivax
| Article | Year |
|---|---|
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines; Recurrence; Risk; Treatment Outcome | 2019 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Vivax; Parasitemia; Primaquine; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfadoxine | 2013 |
Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies.
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Plasmodium vivax; Quinolines; Randomized Controlled Trials as Topic | 2013 |
Prevention and control of malaria in pregnancy - new threats, new opportunities?
Topics: Adult; Animals; Antimalarials; Artemisinins; Culicidae; Drug Combinations; Drug Resistance; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Malaria, Vivax; Pregnancy; Pregnancy Complications, Parasitic; Primary Prevention; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Malaria, Vivax; Quinolines; Treatment Outcome | 2011 |
25 trial(s) available for piperaquine and Malaria, Vivax
| Article | Year |
|---|---|
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2008 |
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2022 |
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines | 2023 |
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women.
Topics: Adult; Antimalarials; Asymptomatic Diseases; Azithromycin; Chemoprevention; Drug Combinations; Erythrocytes; Female; Gestational Age; Humans; Live Birth; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinolines; Random Allocation; Severity of Illness Index; Stillbirth; Sulfadoxine | 2019 |
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Asymptomatic Infections; Female; Humans; Laos; Malaria, Vivax; Male; Mass Drug Administration; Plasmodium vivax; Polymerase Chain Reaction; Primaquine; Quinolines; Recurrence; Time Factors; Young Adult | 2020 |
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mass Drug Administration; Myanmar; Prevalence; Primaquine; Quinolines; Recurrence; Treatment Outcome; Vietnam; Young Adult | 2020 |
Therapeutic and Transmission-Blocking
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Female; Humans; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Quinolines; Young Adult | 2018 |
Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Malaria, Vivax; Male; Middle Aged; Primaquine; Quinolines; Thailand; Young Adult | 2018 |
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Quinolines; Young Adult | 2018 |
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Vivax; Male; Middle Aged; Myanmar; Primaquine; Quinolines; Recurrence; Thailand; Young Adult | 2019 |
Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-la
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Parturition; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Quinolines; Young Adult | 2019 |
A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Humans; Indonesia; Kaplan-Meier Estimate; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Prospective Studies; Quinolines; Treatment Outcome; Young Adult | 2013 |
Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
Topics: Adult; Antimalarials; Artemisinins; Cambodia; Drug Administration Schedule; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Military Personnel; Models, Biological; Quinolines; Recurrence | 2014 |
Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.
Topics: Adolescent; Adult; Aged; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Malaria, Vivax; Male; Maleates; Middle Aged; Peroxides; Quinolines; Spiro Compounds; Young Adult | 2016 |
A Randomized Comparison of Chloroquine Versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Plasmodium vivax; Quinolines; Treatment Outcome; Vietnam; Young Adult | 2016 |
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antimalarials; Artemisinins; Drug Interactions; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Half-Life; Healthy Volunteers; Humans; Lumefantrine; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Quinolines; Young Adult | 2016 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
Topics: Adolescent; Afghanistan; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Vivax; Male; Multivariate Analysis; Plasmodium vivax; Prospective Studies; Quinolines; Recurrence; Treatment Outcome | 2010 |
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Female; Humans; Infant; Malaria, Vivax; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium vivax; Quinolines; Recurrence; Risk Factors; Treatment Outcome; Young Adult | 2011 |
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Chemoprevention; Dietary Fats; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Hematocrit; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Placebos; Plasmodium falciparum; Plasmodium vivax; Quinolines; Risk; Thailand | 2012 |
Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance; Drug Therapy, Combination; Humans; Indonesia; Malaria; Malaria, Vivax; Male; Military Personnel; Plasmodium vivax; Primaquine; Quinine; Quinolines; Secondary Prevention | 2013 |
Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Blood Glucose; Cambodia; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Electrocardiography; Heart Rate; Hematocrit; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Middle Aged; Quinolines; Sesquiterpenes | 2004 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Diarrhea; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Indonesia; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Prospective Studies; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome; Urticaria; Vomiting | 2007 |
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Tolerance; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Quinolines; Sesquiterpenes; Treatment Outcome | 2007 |
18 other study(ies) available for piperaquine and Malaria, Vivax
| Article | Year |
|---|---|
Efficacy and safety of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia.
Topics: Antimalarials; Artemisinins; Humans; Indonesia; Malaria, Vivax; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Piperazines; Primary Health Care; Quinolines; Treatment Outcome | 2022 |
Therapeutic efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium vivax malaria in Seacha area, Arbaminch Zuria District, South West Ethiopia.
Topics: Antimalarials; Artemisinins; Ethiopia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax | 2022 |
Effectiveness of dihydroartemisinin-piperaquine after 10 years as treatment for vivax malaria in Indonesia.
Topics: Adult; Antimalarials; Child; Humans; Indonesia; Malaria; Malaria, Falciparum; Malaria, Vivax; Prospective Studies | 2023 |
Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
Topics: Antimalarials; Biomarkers; Coinfection; Drug Resistance; Humans; Malaria, Vivax; Mutation; Plasmodium vivax; Protozoan Proteins; Thailand | 2023 |
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; DNA Copy Number Variations; Drug Resistance; Humans; Malaria, Vivax; Mefloquine; Pharmaceutical Preparations; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines | 2020 |
Prevalence of CYP2D6 Genotypes and Predicted Phenotypes in a Cohort of Cambodians at High Risk for Infections with
Topics: Antimalarials; Artemisinins; Asian People; Cambodia; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Endemic Diseases; Gene Frequency; Genotype; Humans; Malaria, Vivax; Pharmacogenomic Variants; Phenotype; Plasmodium vivax; Polymorphism, Genetic; Primaquine; Quinolines; Recurrence; Treatment Failure | 2020 |
Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; Humans; Indonesia; Infant; Malaria, Vivax; Male; Middle Aged; Primaquine; Quinolines; Recurrence; Retrospective Studies; Young Adult | 2017 |
Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Healthy Volunteers; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mass Drug Administration; Middle Aged; Papua New Guinea; Patient Safety; Prospective Studies; Quinolines | 2018 |
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Microbial Sensitivity Tests; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Quinolines; Real-Time Polymerase Chain Reaction; Vietnam; Young Adult | 2019 |
Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia.
Topics: Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Cambodia; Drug Resistance; Gene Amplification; Genetic Markers; Genotype; Humans; Laos; Malaria, Vivax; Mutation Rate; Mutation, Missense; Plasmodium vivax; Polymorphism, Genetic; Protozoan Proteins; Quinolines; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand | 2019 |
Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
Topics: Acute Disease; Antimalarials; Artemisinins; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines | 2014 |
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Plasmodium vivax; Protozoan Proteins; Quinolines; Transcription, Genetic; Tubulin | 2016 |
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Cost of Illness; Cross-Sectional Studies; Family Characteristics; Female; Guideline Adherence; Health Expenditures; Humans; Indonesia; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Patient Acceptance of Health Care; Quinolines; Random Allocation; Young Adult | 2016 |
Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission.
Topics: Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Indonesia; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Malaria, Vivax; Population Surveillance; Pregnancy; Prospective Studies; Quinolines; Risk Factors | 2011 |
Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Cambodia; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines; Treatment Outcome; Young Adult | 2013 |
Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.
Topics: Adult; Antimalarials; Child; Dose-Response Relationship, Drug; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Quinolines; Tablets | 2004 |
Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
Topics: Adult; Animals; Antimalarials; Artemisinins; Cross-Sectional Studies; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Surveys and Questionnaires | 2008 |